TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Dividend Stocks
3 Stocks That Will Save You Next Time the Market Crashes
Investing
Have Pot Stocks Finally Run Out of Steam?
Investing
Canopy Growth Corp.: Why its Stock Surged 11% Yesterday
Investing
Why Has Canopy Growth Corp. Dropped Nearly 40% Since the Beginning of the Year?
Tech Stocks
Checklist: 4 Variables to Help us Find a Winning Stock
Investing
3 Marijuana Stocks to Buy Today
Dividend Stocks
4 Things to Remember in Turbulent Times
Investing
Strong Revenue Growth for Canopy Growth Corp., but the Best Is Yet to Come
Investing
It’s Time for Cannabis Investors to Face the Elephant in the Room
Investing
Canopy Growth Corp. Shows the Market How Fast a Weed Should Grow